| Hurricanes and healthcare: a case report on the influences of Hurricane Maria and managed Medicare in treating a Puerto Rican resident G Mellgard, D Abramson, C Okamura, H Weerahandi BMC health services research 19, 1-5, 2019 | 18 | 2019 |
| The impact of androgen deprivation therapy on COVID-19 illness in men with prostate cancer NJ Shah, VG Patel, X Zhong, L Pina, JE Hawley, E Lin, BA Gartrell, ... JNCI cancer spectrum 6 (3), pkac035, 2022 | 10 | 2022 |
| Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors. Q Qin, VG Patel, B Wang, G Mellgard, M Gogerly-Moragoda, X Zhong, ... Journal of Clinical Oncology 38 (15_suppl), e15160-e15160, 2020 | 10 | 2020 |
| The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer. VG Patel, X Zhong, NJ Shah, L Pina Martina, J Hawley, E Lin, BA Gartrell, ... Journal of Clinical Oncology 39 (6_suppl), 41-41, 2021 | 8 | 2021 |
| Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors G Mellgard, VG Patel, X Zhong, H Joshi, Q Qin, B Wang, A Parikh, T Jun, ... Journal of Cancer Research and Clinical Oncology 149 (7), 2833-2841, 2023 | 5 | 2023 |
| Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis Q Qin, T Jun, B Wang, VG Patel, G Mellgard, X Zhong, ... Discover Oncology 13 (1), 73, 2022 | 5 | 2022 |
| Complexity, not severity: Reinterpreting the sliding scale of capacity G Mellgard, N Gligorov Cambridge Quarterly of Healthcare Ethics 31 (4), 506-517, 2022 | 4 | 2022 |
| Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy AB Parikh, X Zhong, G Mellgard, Q Qin, VG Patel, B Wang, P Alerasool, ... American journal of clinical oncology 44 (3), 114-120, 2021 | 4 | 2021 |
| Examining variation in state spending on medicaid long-term services and supports for older adults G Mellgard, C Ankuda, OK Rahman, A Kelley Home health care services quarterly 41 (1), 54-64, 2022 | 3 | 2022 |
| Variants of uncertain significance in precision oncology: nuance or nuisance? GS Mellgard, Z Atabek, M LaRose, F Kastrinos, SE Bates The Oncologist, oyae135, 2024 | 2 | 2024 |
| Lessons from withdrawn accelerated approvals in oncology GS Mellgard, T Fojo, SE Bates Nature Cancer 5 (2), 211-215, 2024 | 2 | 2024 |
| How are we doing? A scoping review of published patient-centered outcomes research in United States student-run free clinics F Silvestri, G Mellgard, J Goldstein, S Chennareddy, J Tang, M Tran, ... Teaching and Learning in Medicine, 1-13, 2023 | 2 | 2023 |
| Smoking status and immunotherapy outcomes in smoking-associated cancers. T Jun, T Ganta, Q Qin, VG Patel, B Wang, G Mellgard, ... Journal of Clinical Oncology 38 (15_suppl), e15097-e15097, 2020 | 2 | 2020 |
| Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. VG Patel, Q Qin, B Wang, M Gogerly-Moragoda, G Mellgard, X Zhong, ... Journal of Clinical Oncology 38 (15_suppl), e15068-e15068, 2020 | 1 | 2020 |
| Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy Z Chakrani, G Mellgard, N Saffran, S McCroskery, N Taylor, M Patel, ... American Journal of Clinical Oncology 47 (6), 271-278, 2024 | | 2024 |
| High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy GS Mellgard, D Bhutani, MY Mapara, MS Maurer, J Radhakrishnan, ... Bone Marrow Transplantation, 1-3, 2024 | | 2024 |
| Evaluation of patient health outcomes of a student-run free clinic in East Harlem JJ Jiang, K Link, G Mellgard, F Silvestri, D Qian, S Chennareddy, M Tran, ... BMC Medical Education 24 (1), 323, 2024 | | 2024 |
| Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma G Mellgard, M Gilligan, ERS Cliff, D Bhutani, GR Mohyuddin, ... HemaSphere 8 (3), 2024 | | 2024 |
| Risk Stratification Models Overestimate Progression Risk in Contemporary Patients with Smoldering Multiple Myeloma (SMM) G Mellgard, M Gilligan, ERS Cliff, D Bhutani, GR Mohyuddin, ... Blood 142, 4768, 2023 | | 2023 |
| Hypereosinophilic syndrome with leptomeningeal involvement: a not-so-classical case report of classical Hodgkin Lymphoma G Mellgard, E Stoffel, A Michel, F Iqbal, A Provenzano, IJ Akpan, ... Leukemia & Lymphoma 64 (13), 2208-2213, 2023 | | 2023 |
